RN7SKP5

Across TCGA pan-cancer cohorts, RN7SKP5 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RN7SKP5’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where RN7SKP5 RNA is repressed in tumor relative to normal tissue. In most cancer types RN7SKP5 is over-expressed in tumor, although a few such as UCEC and KIRC show the opposite, repressed pattern.

UCEC, PRAD, and KIRC are the cancer types where RN7SKP5 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SKP5 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	All	−0.213	.014	2	view →
PRAD	All	All	+0.128	.018	2	view →
KIRC	All	All	−0.047	.015	2	view →
KICH	All	All	−0.075	.026	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

RN7SKP5–UCEC

Open the UCEC breakdown →